SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,100,264 | -21.6% | 8,491 | -33.1% | 0.23% | -25.2% |
| Q3 2022 | $1,403,000 | +47.4% | 12,689 | +45.5% | 0.30% | +17.8% |
| Q4 2018 | $952,000 | -60.1% | 8,722 | -40.9% | 0.26% | -26.8% |
| Q3 2018 | $2,385,000 | -29.8% | 14,766 | -42.5% | 0.35% | -33.8% |
| Q2 2018 | $3,396,000 | +14.7% | 25,692 | -35.7% | 0.54% | +8.5% |
| Q1 2018 | $2,962,000 | +6.6% | 39,980 | -19.9% | 0.49% | -1.0% |
| Q4 2017 | $2,778,000 | +0.1% | 49,920 | -18.4% | 0.50% | +35.0% |
| Q3 2017 | $2,774,000 | -21.0% | 61,155 | +6.9% | 0.37% | -21.8% |
| Q3 2016 | $3,512,000 | – | 57,186 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |